Press Release – Asthma and Respiratory Foundation of New Zealand A new partnership between heat pump company Daikin and the Asthma and Respiratory Foundation NZ (ARFNZ) will see the two organisations work together to help reduce the impact of respiratory illness. As a partner of ARFNZ, and member of the Foundations …
A new partnership between heat pump company Daikin and the Asthma and Respiratory Foundation NZ (ARFNZ) will see the two organisations work together to help reduce the impact of respiratory illness.
As a partner of ARFNZ, and member of the Foundation’s Friends of the Foundation programme, Daikin is focused on improving indoor air quality and highlighting the importance of warm dry homes, which are both key to reducing triggers for respiratory illness and asthma.
Press Release – Asthma and Respiratory Foundation of New Zealand A new partnership between heat pump company Daikin and the Asthma and Respiratory Foundation NZ (ARFNZ) will see the two organisations work together to help reduce the impact of respiratory illness. As a partner of ARFNZ, and member of the Foundations …
A new partnership between heat pump company Daikin and the Asthma and Respiratory Foundation NZ (ARFNZ) will see the two organisations work together to help reduce the impact of respiratory illness.
As a partner of ARFNZ, and member of the Foundation’s Friends of the Foundation programme, Daikin is focused on improving indoor air quality and highlighting the importance of warm dry homes, which are both key to reducing triggers for respiratory illness and asthma.
New Partnership Aims To Improve Indoor Air Quality – And People s Health scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Friday, 19 February 2021, 9:10 am
The first-ever New Zealand COPD (Chronic Obstructive
Pulmonary Disease) Guidelines have been published in the New
Zealand Medical Journal today, providing a national
framework for diagnosis and management of COPD in a New
Zealand context.
Affecting more than 15% of New
Zealand adults over the age of 45, and encompassing
emphysema, chronic bronchitis, and chronic airflow
obstruction, COPD is irreversible and usually progressive.
People with COPD are more at risk to severe illness from
contracting COVID-19, as listed on the Ministry of Health s
website of severe underlying medical conditions.
The
guidelines have been developed by the Asthma and Respiratory